|
Published by: BCC Research
Published: Jan. 1, 2010 - 198 Pages
Table of Contents
- CHAPTER ONE: INTRODUCTION
- STUDY GOALS AND OBJECTIVES
- REASONS FOR DOING THE STUDY
- INTENDED AUDIENCE
- SCOPE OF REPORT
- MARKET ANALYSES AND FORECASTS
- METHODOLOGY
- INFORMATION SOURCES
- ANALYST CREDENTIALS
- RELATED BCC REPORTS
- BCC ONLINE SERVICES
- DISCLAIMER
- CHAPTER TWO: SUMMARY
- RESEARCH AND COMMERCIALIZATION
- APPLICATIONS
- DRUG DELIVERY
- DRUGS AND THERAPY
- IN VIVO IMAGING
- IN VITRO DIAGNOSTICS
- BIOMATERIALS
- ACTIVE IMPLANTS
- MARKET
- SUMMARY TABLE NANOMEDICAL GLOBAL SALES BY THERAPEUTIC AREA, THROUGH 2014 ($ BILLIONS)
- SUMMARY FIGURE NANOMEDICAL GLOBAL SALES BY THERAPEUTIC AREA, 2006-2014 ($ BILLIONS)
- CHAPTER THREE: OVERVIEW
- MEDICAL NANOTECHNOLOGY: NANOMEDICINE
- FUTURE POSSIBILITIES
- MARKET POTENTIAL
- ABOUT NANOTECHNOLOGY
- THE MANY USES OF NANOTECHNOLOGY
- MEDICAL APPLICATIONS
- ENVIRONMENTAL APPLICATIONS
- MILITARY APPLICATIONS
- COSMETICS
- APPLICATIONS IN DEVELOPMENT
- THE TOOLS OF NANOTECHNOLOGY
- C60/FULLERENES
- CARBON NANOTUBES
- NANOPARTICLES
- NANOWIRES
- MOLECULAR NANOTECHNOLOGY
- RISKS OF NANOTECHNOLOGY
- POISON/TOXICITY
- NANOTECHNOLOGY IN THE MARKETPLACE
- CHAPTER FOUR: NANOMEDICINE
- DEVELOPMENT OF NANOMEDICAL TECHNOLOGIES
- TABLE 1 NANOMEDICINE TIMESCALE
- TABLE 2 MAIN NANOTECHNOLOGIES USED IN MEDICINE, WITH APPLICATIONS
- LIPOSOMES
- TABLE 3 MARKETED LIPOSOME NANOPHARMACEUTICALS
- DENDRIMERS
- TABLE 4 DENDRIMER PRODUCTS IN ADVANCED DEVELOPMENT
- NANOCRYSTALS
- TABLE 5 NANOCRYSTAL PHARMACEUTICALS
- MICELLES
- TABLE 6 MARKETED AND DEVELOPMENTAL PRODUCTS IN MICELLE FORM
- FULLERENES
- POLYMERIC NANOPARTICLES
- THERAPEUTIC USES OF NANOMEDICINE
- CANCER DIAGNOSTICS AND THERAPY
- Silica Nanospheres
- Nanoscale Hydrogel Shells
- Photodynamic Therapy and Gold
- Dendrimer Conjugates
- Ligand-targeted Emulsion Technologies
- Linear Cyclodextrin-containing Polymers
- Smart Lipid-based Nanocarriers
- Thermotherapy Using Magnetic Nanoparticles
- Targeted Cell Destruction
- Nanoshells
- DRUG DELIVERY
- Acusphere
- AlphaRx
- Aphios
- Biodelivery Sciences
- Bioral
- Capsulution NanoScience
- HealthPlus International
- IGI
- Labopharm
- MagnaMedics
- Nanocopoeia
- Nanocrystal
- NanoMed
- Nanopharm
- Nanocyte
- Nanotherapeutics
- Nanotrope
- pSivida
- SoluBest
- Spherics
- Telemolecular
- INFECTION CONTROL
- Silver Nanoparticles Against Infection
- Detecting Nanobacteria
- Killing Viruses
- DIAGNOSTIC TOOLS
- BioCrystal/InVitrogen
- BioForce
- Biophage
- CombiMatrix
- Farfield Sensors
- GE Healthcare BioSciences
- Immunicon
- MagnaMedics
- Nanogen
- NanoSphere
- Qiagen
- Sphere
- TransGenex
- Veredus
- VARIOUS THERAPEUTIC TARGETS AND TECHNOLOGIES
- Anthrax
- Cholesterol
- Artificial Retina
- Nerve Regeneration
- Crossing the Blood-Brain Barrier
- Protecting Against Radiation Damage
- Antibody Therapeutics
- Hemostasis
- Bone Fracture Repair
- Dental Implant and Tissue Regeneration
- Vaccine Adjuvant
- Treatment of Thrombosis
- Coatings for Stents and Other Devices
- FUTURE TRENDS AND RESEARCH POSSIBILITIES
- Noninvasive Nanodevices
- Extracellular Devices
- Intracellular Devices
- Nanomachines to Control Tissue Healing
- Eliminating Viruses
- Correcting Chemistry
- New Organs and Limbs
- FUNDAMENTAL NANOTECHNOLOGY RESEARCH
- U.S.
- University at Albany-SUNY
- Cornell University
- University of Michigan
- Rice University
- University of Pennsylvania
- University of Virginia
- University of North Carolina
- Ohio State University
- Northwestern University
- University of Pittsburgh
- Case Western Reserve University
- University of California at Berkeley
- Europe
- TABLE 7 EUROPEAN NANOCENTERS
- Japan
- Development of Active Targeting DDS
- Development of Novel Tissue Engineering
- Development of New Biomaterials
- THE RISK FACTOR
- MARKETS FOR NANOMEDICINE
- TABLE 8 MARKETED NANOPHARMACEUTICALS
- TABLE 9 MARKETED NANO-IMAGING, DIAGNOSTICS, BIOMATERIALS
- MARKET DRIVERS
- MARKET ESTIMATES AND FORECASTS
- TABLE 10 NANOTECHNOLOGY REVENUES BY INDUSTRY SECTOR, 2010 (%)
- Global Nanomedicine Market
- TABLE 11 GLOBAL NANOMEDICINE MARKET, THROUGH 2014 ($ BILLIONS)
- Main Product Categories
- Drug Delivery
- Molecular Diagnostics
- Market Analysis by Clinical Application
- Cancer
- TABLE 12 MAJOR MARKETED ANTICANCER NANOPHARMACEUTICALS, 2008 ($ BILLIONS)
- TABLE 13 MARKET FORECAST FOR CANCER NANOTHERAPEUTICS AND ANODIAGNOSTICS, THROUGH 2014 ($ BILLIONS)
- CNS Disorders
- TABLE 14 MAJOR MARKETED CNS NANOPHARMACEUTICALS, 2008 ($ MILLIONS)
- TABLE 15 MARKET FORECAST FOR CNS NANOMEDICINES, THROUGH 2014 ($ BILLIONS)
- Infection
- TABLE 16 MAJOR MARKETED ANTI-INFECTIVE NANOPHARMACEUTICALS, 2008 ($ BILLIONS)
- TABLE 17 MARKET FORECAST FOR ANTI-INFECTION NANOTHERAPEUTICS AND NANODIAGNOSTICS, THROUGH 2014 ($ BILLIONS)
- Cardiovascular and Autoimmune Disorders
- TABLE 18 MAJOR MARKETED NANOMEDICINES FOR CARDIOVASCULAR AND INFLAMMATORY DISEASES, 2008 ($ MILLIONS)
- TABLE 19 MARKETS FOR CARDIOVASCULAR AND ANTIINFLAMMATORY PRODUCTS, THROUGH 2014 ($ BILLIONS)
- Regional and National Market Analysis
- FIGURE 1 NATIONAL SHARES OF THE GLOBAL NANOMEDICINE MARKETPLACE, 2009 (%)
- U.S.
- TABLE 20 U.S. NANOMEDICINE MARKET: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
- Japan
- TABLE 21 NANOMEDICINE MARKET IN JAPAN: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
- Europe
- TABLE 22 NANOMEDICINE MARKET IN GERMANY: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
- TABLE 23 NANOMEDICINE MARKET IN FRANCE: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
- TABLE 24 NANOMEDICINE MARKET IN UNITED KINGDOM: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
- TABLE 25 NANOMEDICINE MARKET IN ITALY: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
- TABLE 26 NANOMEDICINE MARKET IN SPAIN: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLION/%)
- CHAPTER FIVE: COMPANY PROFILES
- ABLYNX NV
- ABRAXIS BIOSCIENCE
- ACRYMED INC.
- ACUSPHERE INC.
- ADVANCED MAGNETICS
- ALLTRACEL
- ALPHARX INC.
- ANSON NANO-BIOTECHNOLOGY
- APHIOS CORP.
- PROTEIN NANOPARTICLES
- POLYMER NANOSPHERES
- PHOSPHOLIPID NANOSOMES
- BIOCRYSTAL LTD
- BIOFORCE NANOSCIENCES INC.
- THE VIRICHIP VIRUS DETECTION PLATFORM
- BIO-GATE AG
- MEDICAL APPLICATIONS
- BIOPHAGE PHARMA INC.
- PRODUCTS
- DEVELOPMENT THROUGH COLLABORATIONS:
- PHAGES
- BIOPHAN TECHNOLOGIES
- BIOSANTÉ PHARMACEUTICALS INC.
- NOVEL VACCINE ADJUVANT-BIOVANT
- THERAPEUTIC DRUG DELIVERY PLATFORM—BIOAIR /BIOORAL
- CALANDO PHARMACEUTICALS
- C SIXTY
- CAPSULUTION PHARMA AG
- DRUG DELIVERY SYSTEMS
- COMBIMATRIX
- DRUG DEVELOPMENT
- DAMAGE PREVENTION CONCEPT
- ELAN DRUG TECHNOLOGIES
- FARFIELD SCIENTIFIC
- GE HEALTHCARE LIFE SCIENCES
- HEALTHPLUS INTERNATIONAL INC.
- IGI INC.
- IMARX THERAPEUTICS INC.
- SONOLYSIS
- JR NANOTECH PLC
- KEREOS, INC.
- MRI AGENT FOR TUMOR DETECTION
- TARGETED CHEMOTHERAPEUTICS FOR SOLID TUMORS
- KI-0002 MRI AGENT FOR CARDIOVASCULAR DISEASE DETECTION
- ANTI-RESTENOTIC
- KEYSTONE NANO, INC.
- NANOJACKETS
- KLEINDIECK NANOTECHNIK
- NANOWORKSTATION
- LABOPHARM INC.
- LIPLASOME PHARMA
- LUMERA CORPORATION
- NANOCAPTURE MICROARRAYS
- MAGFORCE NANOTECHNOLOGIES AG
- MAGNAMEDICS GMBH
- MAGCUSTOM
- Customized Nano- and Micro-Particles
- EFFICIENT AND LOW-COST DIAGNOSTICS
- MULTIFUNCTIONAL DRUG CARRIER
- MICROFLUIDICS INTERNATIONAL CORPORATION
- MIV THERAPEUTICS INC.
- CARDIOVASCULAR HEART STENTS
- MOLECULAR PROFILES
- NANOBAC PHARMACEUTICALS INC
- NANOBIO CORPORATION
- NANOBIOTIX
- NANOCARRIER CO. LTD.
- NANOCOPOEIA
- NANOCYTE INC
- NANOGEN INC.
- ELECTRONIC MICROARRAY
- INSTRUMENTATION
- Molecular Biology Workstation
- Molecular Biology Workstation Cartridge
- NanoChip 400 System
- NANOINK INC.
- NANOLOGIX INC.
- NANOMED PHARMACEUTICALS, INC.
- NANOMIX INC.
- NANOPHARM AG
- NANOSPECTRA BIOSCIENCES, INC.
- NANOSPHERE INC.
- NANOSTRUCTURES INC.
- NANOSYN INC
- NANOTHERAPEUTICS INC.
- NANOTROPE INC.
- NANOVIRICIDES INC.
- FLUCIDE-I
- NUCRYST PHARMACEUTICALS
- WEBSITE: WWW.NUCRYST.COM
- NUTRALEASE
- ORION INTEGRATED BIOSCIENCES INC.
- GENOMIC SIGNATURES
- RATIONAL ANTIVIRAL DEVELOPMENT
- DISCOVERY OF MALARIA INVASION PATHWAYS
- ORTHOVITA INC
- PIONEER SURGICAL TECHNOLOGY
- PSIVIDA LTD
- QIAGEN N.V.
- SOLUBEST LTD.
- SPHERICS INC.
- STARPHARMA HOLDINGS LTD
- DENDRIMER NANOTECHNOLOGY
- TECAN GROUP LTD.
- TEMOLECULAR CORPORATION
- TRANSGENEX NANOBIOTECH INC.
- THERAPY
- APPENDIX: GLOSSARY OF TERMS
- TABLE 27 GLOSSARY OF TERMS
- LIST OF TABLES
- SUMMARY TABLE NANOMEDICAL GLOBAL SALES BY THERAPEUTIC
- AREA, THROUGH 2014 ($ BILLIONS)
- TABLE 1 NANOMEDICINE TIMESCALE
- TABLE 2 MAIN NANOTECHNOLOGIES USED IN MEDICINE, WITH
- APPLICATIONS
- TABLE 3 MARKETED LIPOSOME NANOPHARMACEUTICALS
- TABLE 4 DENDRIMER PRODUCTS IN ADVANCED DEVELOPMENT
- TABLE 5 NANOCRYSTAL PHARMACEUTICALS
- TABLE 6 MARKETED AND DEVELOPMENTAL PRODUCTS IN
- MICELLE FORM
- TABLE 7 EUROPEAN NANOCENTERS
- TABLE 8 MARKETED NANOPHARMACEUTICALS
- TABLE 9 MARKETED NANO-IMAGING, DIAGNOSTICS,
- BIOMATERIALS
- TABLE 10 NANOTECHNOLOGY REVENUES BY INDUSTRY SECTOR,
- 2010 (%)
- TABLE 11 GLOBAL NANOMEDICINE MARKET, THROUGH 2014 ($
- BILLIONS)
- TABLE 12 MAJOR MARKETED ANTICANCER
- NANOPHARMACEUTICALS, 2008 ($ BILLIONS)
- TABLE 13 MARKET FORECAST FOR CANCER NANOTHERAPEUTICS
- AND ANODIAGNOSTICS, THROUGH 2014 ($ BILLIONS)
- TABLE 14 MAJOR MARKETED CNS NANOPHARMACEUTICALS, 2008
- ($ MILLIONS)
- TABLE 15 MARKET FORECAST FOR CNS NANOMEDICINES,
- THROUGH 2014 ($ BILLIONS)
- TABLE 16 MAJOR MARKETED ANTI-INFECTIVE
- NANOPHARMACEUTICALS, 2008 ($ BILLIONS)
- TABLE 17 MARKET FORECAST FOR ANTI-INFECTION
- NANOTHERAPEUTICS AND NANODIAGNOSTICS, THROUGH 2014
- ($ BILLIONS)
- TABLE 18 MAJOR MARKETED NANOMEDICINES FOR
- CARDIOVASCULAR AND INFLAMMATORY DISEASES, 2008 ($
- MILLIONS)
- TABLE 19 MARKETS FOR CARDIOVASCULAR AND ANTIINFLAMMATORY
- PRODUCTS, THROUGH 2014 ($ BILLIONS)
- TABLE 20 U.S. NANOMEDICINE MARKET: HISTORIC AND FORECAST
- DATA, THROUGH 2014 ($ BILLIONS/%)
- TABLE 21 NANOMEDICINE MARKET IN JAPAN: HISTORIC AND
- FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
- TABLE 22 NANOMEDICINE MARKET IN GERMANY: HISTORIC AND
- FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
- TABLE 23 NANOMEDICINE MARKET IN FRANCE: HISTORIC AND
- FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
- TABLE 24 NANOMEDICINE MARKET IN UNITED KINGDOM:
- HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
- TABLE 25 NANOMEDICINE MARKET IN ITALY: HISTORIC AND
- FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
- TABLE 26 NANOMEDICINE MARKET IN SPAIN: HISTORIC AND
- FORECAST DATA, THROUGH 2014 ($ BILLION/%)
- TABLE 27 GLOSSARY OF TERMS
- LIST OF FIGURES
- SUMMARY FIGURE NANOMEDICAL GLOBAL SALES BY
- THERAPEUTIC AREA, 2006-2014 ($ BILLIONS)
- FIGURE 1 NATIONAL SHARES OF THE GLOBAL NANOMEDICINE
- MARKETPLACE, 2009 (%)
AbstractTHIS REPORT:
- Develops projections for the global nanomedicine market and for selected national markets, as well as the global markets by major nanotechologies and clinical applications. It will provide data for 2008 and estimates for 2009, and forecast the market and its compound annual growth rate (CAGR) from 2009 to 2014.
- Discusses clinical applications to be developed, including cancer diagnosis and therapy, drug-delivery systems, biosensors, bone and dental repair, and coatings, such as those for stents.
- Describes nanotechnologies such as fullerenes (buckyballs) as drug carriers, nanotubules for drug delivery, nanoparticles (e.g., liposomes, dendrimers, micelles), nanospheres, and molecular nanotechnology.
- Explains that financing for start-up businesses is derived from various sources, including venture capital and government grants, and that there is also a considerable amount of activity in university research laboratories and scientific foundations.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
